* BIO-Key International Inc BKYI.OQ reported a quarterly
adjusted loss of 29 cents per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 16 cents per share.
* Revenue rose 5.8% to $1.37 million from a year ago;
analysts
expected $2.40 million.
* BIO-Key International Inc's reported EPS for the quarter
was a
loss of 29 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIO-Key International Inc shares had risen by 2.0% this
quarter and lost 29.4% so far this year.
* The company reported a quarterly loss of $2.4 million.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $4.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
15 at 05:06 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.16 -0.29 Missed
Jun. 30 2022 -0.08 -0.21 Missed
Mar. 31 2022 -0.22 -0.12 Beat
Dec. 31 2021 -0.15 -0.26 Missed